Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05782465 · ClinicalTrials.gov registry record
Validation of a Molecular Test for Risk-stratification of Patients With High-risk Intestinal Metaplasia (GCEP2 Study)
A clinical trial of Stomach Neoplasm, sponsored by National University Hospital, Singapore.
- Active
- Registry status
- 500
- Enrollment target
- 8
- Study locations
NCT05782465 is a study of Stomach Neoplasm that is active but no longer recruiting, run by National University Hospital, Singapore. The registered enrollment target is 500 participants. The trial reports 8 study locations across 3 states.
The verdict
NCT05782465, a study of Stomach Neoplasm, is active but no longer recruiting, sponsored by National University Hospital, Singapore.
- ACTIVE NOT RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 8
- Study locations
Study Summary
This study is carried out to find out if a customized molecular test can identify a subgroup of patients with very-high-risk of developing stomach cancer within patients with intestinal metaplasia (IM). The investigators hypothesise that the incidence of dysplasia and GC cases in the molecular-test-positive group will be significantly higher than that in the molecular-test-negative group. Such a test has the potential to guide clinicians to better manage patients with IM by allowing endoscopic surveillance to be focused on individuals at very-high-risk of developing stomach cancer, at the same time avoiding or reducing endoscopies for those at lower risk.
Conditions Studied
Interventions
- PROCEDURE Blood Collection, processing and analyses
- PROCEDURE Gastroscopy and biopsies collection
- DIAGNOSTIC_TEST Urea Breath Test
Study Locations (8)
Other
- The Chinese University of Hong Kong - Hong Kong
- Nihon University School of Medicine - Tokyo
- National University Hospital - Singapore
- Yonsei University, Republic of Korea - Seoul
- National Taiwan University Hospital - Taipei
Singapore
- Singapore General Hospital - Singapore
- Tan Tock Seng Hospital, Singapore - Singapore
California
- Stanford University - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2019-08-23 |
| Est. Completion | 2033-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05782465
The ClinicalTrials.gov registry entry for NCT05782465 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National University Hospital, Singapore, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Stomach Neoplasm appearing as the primary indexed condition, and to 3 interventions - of which Blood Collection, processing and analyses is the first listed.
NCT05782465 reports 8 study locations spanning 3 distinct geographic areas - top geographies include Other, Singapore, California.
Frequently Asked Questions
What is clinical trial NCT05782465 about?
NCT05782465 is a clinical study titled "Validation of a Molecular Test for Risk-stratification of Patients With High-risk Intestinal Metaplasia (GCEP2 Study)". This study is carried out to find out if a customized molecular test can identify a subgroup of patients with very-high-risk of developing stomach cancer within patients with intestinal metaplasia (IM). The investigators hypothesise that the incidence of dysplasia and GC cases in the molecular-test-...
What is the current status of trial NCT05782465?
This trial is currently active not recruiting. The enrollment target is 500 participants. The study started on 2019-08-23. Estimated completion is 2033-12.
What conditions does trial NCT05782465 study?
This clinical trial studies the following conditions: Stomach Neoplasm.
What interventions are being tested in trial NCT05782465?
The interventions under investigation include: Blood Collection, processing and analyses (PROCEDURE), Gastroscopy and biopsies collection (PROCEDURE), Urea Breath Test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05782465?
This trial is sponsored by National University Hospital, Singapore, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05782465 being conducted?
This trial has 8 study locations across California, Singapore. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.